This hypothesis is also supported by the finding that PNPLA3 E434K, a variant that decreases PNPLA3 expression, can attenuate the effect of I148M on hepatic steatosis and steatohepatitis[32]. This evidence concerns the gene PNPLA3 and fatty liver disease.